Pay in 4 interest-free payments of $7.36 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
In litigation filed in early 2026, a major GLP-1 manufacturer alleged that testing of compounded injectable semaglutide products found impurity levels as high as 86%, with compounded oral formulations containing impurities as high as 75%
These changes occur due to both reduced calorie intake and early metabolic effects
It uses the same tirzepatide molecule as compounded versions, but with FDA oversight, single-dose delivery, and a clear legal status
The safest choice is to dispose of it according to your pharmacy's medication disposal guidelinesmany offer free take-back programs, or the FDA recommends placing used needles and vials in a sharps container and consulting local household hazardous waste facilities
US$ 21.16
US$ 28.50
US$ 22.03
US$ 20.13
